在使用oHSV-mshPKRR进行型病毒治疗期间,阻断反对脑瘤抗原呈现的免疫抑制
Nobushige Tsuboi1, Kimberly A Rivera-Caraballo1, Upasana Sahu1
1Department of Pathology, Georgia Cancer Center at Augusta University, Augusta, Georgia.
Molecular cancer therapeutics
|December 23, 2024
概括
在质母细胞瘤 (GBM) 中禁用瘤蛋白激酶R (PKR) 信号,激活免疫抑制性胺二氧化酶 (IDO) 途径. 将性病毒疗法与IDO抑制剂结合起来,可以增强抗瘤免疫力,减少瘤生长.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有攻击性的脑瘤.
- 经过工程设计以禁用蛋白激酶R (PKR) 信号传导 (oHSV-shPKR) 的瘤性简单性疹病毒显示出对GBM治疗的前景.
- 在GBM中抑制PKR可能会影响瘤免疫微环境.
研究的目的:
- 研究使瘤内在PKR信号失效对GBM中胺2,3-二氧化酶 (IDO) 途径的影响.
- 评估将oHSV-shPKR与IGO抑制剂 (英多西莫德) 结合用于GBM治疗的治疗潜力.
主要方法:
- 感染oHSV的人类GBM神经圈与单细胞衍生的树突细胞 (MoDCs) 的共同培养.
- 对IDO信号通路激活,托芬消耗和MoDC激活的分析.
- 在体内对瘤生长抑制和抗原特异性CD8+T细胞激活的评估.
主要成果:
- 禁用瘤-PKR信号诱导了IDO通路激活和增加了IDO+CD11c+树突细胞 (DC) 在GBM瘤中的透.
- GBM神经圈的oHSV感染通过I型IFN信号在MoDC中增强了IDO信号.
- 配合印克西莫德和oHSV的联合治疗显著抑制了GBM瘤的生长,并促进了抗原特异性CD8+T细胞的反应.
结论:
- 在GBM中禁用瘤内在PKR信号激活了免疫抑制性IDO通路.
- 抑制IDO途径可以在GBM的型病毒疗法期间克服反免疫抑制.
- 联合oHSV和IDO抑制是一种增强GBM免疫疗法的有希望的策略.
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
01:29Immune Response Against Viral Pathogens
745
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
745